Biotechnology

Streetwise newsletter: Lockdown a ‘multi-layered crisis for Canada,’ IMF chief economist says

Vancouver biotech company studying antibodies that could buy time in the race for a coronavirus vaccine

Novartis to buy U.S. biotech The Medicines Co. for $9.7 billion